Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Growth hormone therapy dosing

Thyroid function tests are often altered by somatropin because of increased conversion of T4 to T3, but this is clinically insignificant at low doses (SEDA-21, 453). One child with Prader-Willi syndrome had a fall in serum thyroxine concentration during somatropin therapy and needed thyroxine replacement (33). Hypothyroidism developed in 11 of 46 growth hormone-deficient children treated with somatropin (34). Prior abnormalities in hypothalamic-pituitary function and alterations in thyroid hormone metabolism, probably both, contributed to the high incidence of hypothyroidism, which was similar to that in previous studies. [Pg.510]

Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, Monson JP. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998 83(ll) 3913-9. [Pg.515]

Toogood AA, Shalet SM. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease a dose-finding study. J Clin Endocrinol Metab 1999 84(l) 131-6. [Pg.516]

Chew SL, Grossman AB, Besser GM, Monson JP. 67. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy a two year study, din Endocrinol (Oxf) 2000 53(4) 453-9. [Pg.517]

Rosenfalck AM, Maghsoudi S, Fisker S, Jorgensen JO, Christiansen JS, Hilsted J, Volund AA, Madsbad S. The 68. effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin... [Pg.517]

Blethen S. Dosing, monitoring, and safety of growth hormone-replacement therapy in adults with growth hormone deficiency. Endocrinologist 1998 8 S36-40. [Pg.517]

In many cases the most important aspect of structural studies is that knowledge of the structure of a protein leads to improved understanding of its function. For instance, if a protein has to be administered for lifetime or long-firm TAnjswmnii therapy (c.g, insulin, growth hormone, factor IX), it is import tant to know all about its stmcture-function-stability relationships. A longer turnover time or a higher specific activity, for example, allows for a smaller dose to... [Pg.74]


See other pages where Growth hormone therapy dosing is mentioned: [Pg.856]    [Pg.910]    [Pg.911]    [Pg.148]    [Pg.515]    [Pg.730]    [Pg.823]    [Pg.34]    [Pg.514]    [Pg.515]    [Pg.387]    [Pg.388]    [Pg.457]    [Pg.122]    [Pg.404]    [Pg.816]    [Pg.930]    [Pg.3167]    [Pg.3169]    [Pg.560]    [Pg.1411]    [Pg.1411]    [Pg.1415]    [Pg.1415]    [Pg.1415]    [Pg.1416]    [Pg.2360]    [Pg.114]    [Pg.194]    [Pg.657]    [Pg.26]    [Pg.68]    [Pg.224]    [Pg.243]    [Pg.445]    [Pg.40]    [Pg.684]    [Pg.234]   
See also in sourсe #XX -- [ Pg.1416 ]




SEARCH



Growth hormone therapy

Growth hormones

Hormonal therapy

Hormonal therapy Hormones

Hormone therapy

© 2024 chempedia.info